Reversal of Alopecia Universalis by Tofacitinib: A Case Report
November 2016
in “
Annals of Internal Medicine
”
TLDR Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.
The document from 2016 reported on the use of tofacitinib citrate, a drug approved for rheumatoid arthritis, in treating alopecia universalis. It described two cases where patients experienced progressive hair growth after prolonged administration of tofacitinib, with no adverse events noted after 9 months. Despite these positive outcomes, the authors warned of potential serious side effects from long-term use of Janus kinase inhibitors and called for clinical trials to assess the treatment's efficacy and safety for alopecia universalis. The exact number of participants was not provided.